Home / Product Catalogue / Retatrutide 30mg
Retatrutide 30mg
30 mg / 3 ml solution for injection · multi-dose pre-filled pen
Retatrutide 30mg is supplied as a multi-dose pre-filled pen containing 30 mg of retatrutide in 3 ml of solution (10 mg/ml). The Patient Information Leaflet describes retatrutide as an investigational triple-hormone receptor agonist (targeting the GLP-1, GIP and glucagon receptors).
For directions for use, precautions, possible side effects and full product information, read the Patient Information Leaflet.
Pharma grade quality control
Independently verified
Robust research support
Product details
Retatrutide 30 mg
30 mg in 3 ml solution (10 mg/ml)
Multi-dose pre-filled injector pen (300 clicks total capacity)
Benzyl alcohol (preservative) and other excipients as per formulation
Subcutaneous injection
1 × multi-dose pre-filled pen, 8 × disposable injection needles
Refrigerate at 2–8 °C. Do not freeze. Protect from light and keep in the original packaging. See the leaflet for short periods below 30 °C.
Supplied for research, investigational or off-label use under strict medical supervision only. Not a marketed product.
Details are taken from the product’s Patient Information Leaflet and pack. The leaflet is the authoritative source.
Read the full leaflet before use
The Patient Information Leaflet sets out how to use this product, who should not use it, precautions, possible side effects, storage and pack contents. Always use it as directed by a qualified healthcare professional.
Retatrutide 30mg · PDF · opens in a new tab
